HIGHLIGHTS
- who: Kailun Fei and colleagues from the Xiangya Hospital, Central South, China have published the research work: Effectiveness of neoadjuvant immunochemotherapy compared to neoadjuvant chemotherapy in non-small cell lung cancer patients: Real-world data of a retrospective, dual-center study, in the Journal: (JOURNAL) of November/15,/2022
- what: This study retrospectively analyzed the real-world data of NICT in Cancer Hospital, Chinese Academy of Medical Sciences and Shanxi Provincial Cancer Hospital to explore its effectiveness and safety. This study compared the data of dual-center Efficacy in patients with driver mutations Unlike the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.